In Japan, active pharmaceutical ingredients (APIs) are assessed during audits through rigorous inspections focusing on manufacturing processes, quality control systems, and compliance with Good Manufacturing Practices (GMP). Auditors evaluate documentation, traceability, and testing procedures to ensure API safety, efficacy, and consistency, aligning with Japanese regulatory standards and international guidelines.